Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2011

Open Access 01-12-2011 | Research article

BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants

Authors: Azzeme Harun, Richard Muhammad Johari James, Siong Meng Lim, Abu Bakar Abdul Majeed, Anthony LJ Cole, Kalavathy Ramasamy

Published in: BMC Complementary Medicine and Therapies | Issue 1/2011

Login to get access

Abstract

Background

BACE1 was found to be the major β-secretase in neurons and its appearance and activity were found to be elevated in the brains of AD patients. Fungal endophytic extracts for BACE1 inhibitory activity and cytotoxicity against PC-12 (a rat pheochromocytoma with neuronal properties) and WRL68 (a non-tumorigenic human hepatic) were investigated.

Methods

Endophytes were isolated from plants collected from Kuala Pilah, Negeri Sembilan and the National Park, Pahang and the extracts were tested for BACE1 inhibition. For investigation of biological activity, the pure endophytic cultures were cultivated for 14 days on PDA plates at 28°C and underwent semipolar extraction with ethyl acetate.

Results

Of 212 endophytic extracts (1000 μg/ml), 29 exhibited more than 90% inhibition of BACE1 in the preliminary screening. Four extracts from isolates HAB16R13, HAB16R14, HAB16R18 and HAB8R24 identified as Cytospora rhizophorae were the most active with IC50(BACE1) values of less than 3.0 μg/ml. The most active extract HAB16R13 was shown to non-competitively inhibit BACE1 with K i value of 10.0 μg/ml. HAB16R13 was considered non-potent against PC-12 and WRL68 (IC50(CT) of 60.0 and 40.0 μg/ml, respectively).

Conclusions

This first report on endophytic fungal extract with good BACE1 inhibitory activity demonstrates that more extensive study is required to uncover the potential of endophytes.
Appendix
Available only for authorised users
Literature
1.
Yates D, McLoughlin DM: The molecular pathology of Alzheimer's disease. Psychiat. 2007, 7: 1-5.CrossRef
2.
Vas CJ, Rajkumar S, Tanyakitpisal P, Chandra V: Alzheimer's disease: of emerging importance. Reg Health Forum. 2002, 6: 39-48.
3.
Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E: Inhibition of human cholinesterases by drugs used to treat Alzheimer's disease. Alz Dis Assoc Dis. 2003, 17: 117-126. 10.1097/00002093-200304000-00011.CrossRef
4.
Sisodia SS, Price DL: Role of the β-amyloid protein in Alzheimer's disease. FASEB J. 1995, 9: 366-370.PubMed
5.
Citron M: β-secretase as a target for the treatment of Alzheimer's disease. J Neurosci Res. 2002, 70: 373-379. 10.1002/jnr.10393.CrossRefPubMed
6.
Hardy J, Allsop D: Amyloid deposition as the central event in the etiology of Alzheimer's disease. Trends Pharmacol. 1991, 12: 383-388.CrossRef
7.
Vassar R: β-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Deliver Rev. 2002, 54: 1589-1602. 10.1016/S0169-409X(02)00157-6.CrossRef
8.
Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, John V: Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature. 1999, 402: 537-540. 10.1038/990114.CrossRefPubMed
9.
Dewachter I, Van Leuven F: Secretases as targets for the treatment of Alzheimer's disease: the prospects. Lancet Neurol. 2002, 1: 409-416. 10.1016/S1474-4422(02)00188-6.CrossRefPubMed
10.
Jeon SY, Bae K, Seong YH, Song KS: Green tea catechins as a BACE1 (β-secretase) inhibitor. Bioorg Med Chem Lett. 2003, 13: 3905-3908. 10.1016/j.bmcl.2003.09.018.CrossRefPubMed
11.
Bacon CW, White JF, Stone JK: An overview of endophytic microbes: endophytism defined. Microbial endophytes. Edited by: Bacon CW, White JF. 2000, New York: Marcel Deker, Inc, 3-29. 1
12.
Dreyfuss MM, Chapela IH: Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals. The discovery of natural products with therapeutic potential. Edited by: Gullo VP. 1994, London, UK: Butterworth-Heinemann, 49-80.CrossRef
13.
Ramasamy K, Lim SM, Abu Bakar H, Ismail N, Ismail MS, Ali MF, Weber JFF, Anthony LJC: Antimicrobial and cytotoxic activities of Malaysian endophytes. Phytother Res. 2010, 24: 640-643. 10.1002/ptr.2891.CrossRefPubMed
14.
Hazalin AMN, Ramasamy K, Lim SM, Abdul Wahab I, Cole ALJ, Majeed ABA: Cytotoxic and antibacterial activities of endophytic fungi isolated from plants at the National Park, Pahang, Malaysia. BMC Comp Alt Med. 2009, 9: 46-10.1186/1472-6882-9-46.CrossRef
15.
Acquati F, Accarino M, Nucci C, Fumagalli P, Jovine L, Ottolenghi S, Taramelli R: The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 2000, 468: 59-64. 10.1016/S0014-5793(00)01192-3.CrossRefPubMed
16.
Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, Vassar R: Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem. 2000, 275: 20647-20651. 10.1074/jbc.M002688200.CrossRefPubMed
17.
Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, Tew DG, Meek TD, Chapman C, Schneider K, Ratcliffe SJ, Tattersall D, Testa TT, Southan C, Ryan DM, Simmons DL, Walsh FS, Dingwall C, Christie G: ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci. 2000, 16: 609-619. 10.1006/mcne.2000.0884.CrossRefPubMed
18.
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.CrossRefPubMed
19.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22: 4673-4680. 10.1093/nar/22.22.4673.CrossRefPubMedPubMedCentral
20.
21.
Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39: 783-791. 10.2307/2408678.CrossRef
22.
Nei M, Kumar S: Molecular evolution and phylogenetics. 2000, Oxford University Press, New York, Inc;, 1
23.
Boik J: Cancer at cellular level: cytosine methylation and DNA: a note on cancer prevention. Natural compounds in cancer therapy. Edited by: Farnell S. 2001, Minnesota: Oregon Medical Press, 25-
24.
Phongpaichit S, Kummee S, Nilrat L, Itarat A: Antimicrobial activity of oil from the root of Cinnamomum porrectum. Songklanakarin. J Sci Technol. 2006, 29: 11-16.
25.
Cousins D, Huffman MA: Medicinal properties in the diet of gorillas: an ethno- pharmacological evaluation. Afr Study Monogr. 2002, 23: 65-89.
26.
He H, Janso JE, Williamson RT, Yang HY, Carter GT: Cytosporacin, a highly unsaturated polyketide: application of the ACCORD-ADEQUATE experiment to the structural determination of natural products. J Org Chem. 2003, 68: 6079-6082. 10.1021/jo030067f.CrossRefPubMed
27.
Gurusiddaiah S, Ronald RC: Grahamimycins: Antibiotics from Cytospora sp. Ehrenb. W.F.P.L 13A. Antimicrob Agents. 1981, 19: 153-165.CrossRef
28.
Singh MP, Janso JE, Brady SF: Cytoskyrins and cytosporones produced by Cytospora sp. CR200: taxonomy, fermentation and biological activities. Mar Drugs. 2007, 5: 71-84. 10.3390/md503071.CrossRefPubMedPubMedCentral
29.
Hall JD, Duncan-Gould NW, Siddiqi NA, Kelly JN, Hoeferlin LA, Morrison SJ, Wyatt JK: Cytosporone E: racemic synthesis and preliminary antibacterial testing. Bioorgan Med Chem. 2005, 13: 1409-1413. 10.1016/j.bmc.2004.10.018.CrossRef
30.
Jayasuriya H, Guan Z, Polishook JD, Dombrowski AW, Felock PJ, Hazuda DJ, Singh SB: Isolation, structure, and HIV-1 integrase inhibitory activity of cytosporic acid, a fungal metabolite produced by a Cytospora sp. J Nat Prod. 2003, 66: 551-553. 10.1021/np020533g.CrossRefPubMed
31.
Gosh AK, Gemma S, Tang J: β-secretase as a therapeutic target for Alzheimer's disease. Neurotherapeutics. 2008, 5: 399-408. 10.1016/j.nurt.2008.05.007.CrossRef
32.
Cumming JN, Iserloh U, Kennedy ME: Design and development of BACE1 inhibitors. Curr Opin Drug Discovery Devrl. 2004, 7: 536-56.
33.
Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR, Rajapakse HA, Lai M, Lai MT, Crouthamel MC, Xu M, Tugusheva K, Lineberger JE, Pietrak BL, Espeseth AS, Shi XP, Chen-Dodson E, Holloway MK, Munshi S, Simon AJ, Kuo L, Vacca JP: Structure-based design of potent and selective cellpermeable inhibitors of human β-secretase (BACE-1). J Med Chem Lett. 2004, 47: 6447-50.CrossRef
34.
Ramakrishna NVS, Kumar EKSV, Kulkarn AS, Jain AK, Bhat RG, Parkh S: Screening of natural products for new leads as inhibitors of β-amyloid production: latifolin from Dalbergia sissoo. Indian J Chem. 2001, 40: 539-40.
35.
Je JY, Kim SK: Water-soluble chitosan derivatives as a BACE1 inhibitor. Bioorg Med Chem Lett. 2005, 13: 6551-5. 10.1016/j.bmc.2005.07.004.CrossRef
36.
Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, Jeong HH, Hur JM, Kang YH, Song KS: β-secretase (BACE1) inhibitors from Pomegranate (Punica granatum) husk. Arch Pharm Res. 2005, 28: 1328-32. 10.1007/BF02977896.CrossRefPubMed
37.
Park IH, Jeon SY, Lee HJ, Kim SI, Song KS: A β-secretase (BACE1) inhibitor hispidin from the mycelial cultures of Phellinus linteus. Planta Med. 2004, 70: 143-6.CrossRefPubMed
38.
Lee HJ, Seong YH, Bae KH, Kwon SH, Kwak HM, Nho SK, Kim KA, Hur JM, Lee KB, Kang YH, Song KS: Beta-secretase (BACE1) inhibitors from Sanguisorbae radix. Arch Pharm Res. 2005, 28: 799-803. 10.1007/BF02977345.CrossRefPubMed
39.
Lee DH, Lee DH, Lee JS: Characterization of a new antidementia β-secretase inhibitory peptide from Saccharomyces cerevisiae. Enzyme Microb Tech. 2007, 42: 83-88. 10.1016/j.enzmictec.2007.08.003.CrossRef
Metadata
Title
BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants
Authors
Azzeme Harun
Richard Muhammad Johari James
Siong Meng Lim
Abu Bakar Abdul Majeed
Anthony LJ Cole
Kalavathy Ramasamy
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2011
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-11-79

Other articles of this Issue 1/2011

BMC Complementary Medicine and Therapies 1/2011 Go to the issue

Research article

Prevention of hepatorenal toxicity with Sonchus asper in gentamicin treated rats

Research article

Anti-spasmodic action of crude methanolic extract and a new compound isolated from the aerial parts of Myrsine africana

Research article

Attitudes towards complementary and alternative medicine in chronic pain syndromes: a questionnaire-based comparison between primary headache and low back pain

Research article

Piper sarmentosum inhibits ICAM-1 and Nox4 gene expression in oxidative stress-induced human umbilical vein endothelial cells

Research article

Association of Health Literacy with Complementary and Alternative Medicine Use: A Cross-Sectional Study in Adult Primary Care Patients

Research article

Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial